Provided by Tiger Trade Technology Pte. Ltd.

MoonLake Immunotherapeutics

15.31
-0.4550-2.89%
Volume:268.92K
Turnover:4.14M
Market Cap:1.30B
PE:-4.01
High:15.68
Open:15.68
Low:15.25
Close:15.76
52wk High:62.75
52wk Low:5.95
Shares:85.11M
Float Shares:55.47M
Volume Ratio:1.00
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8139
EPS(LYR):-3.5300
ROE:-67.47%
ROA:-32.44%
PB:3.04
PE(LYR):-4.34

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 10, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 10, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Jul 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2026

Major Issues Report

Form 8-K - Current report
Jun 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 25, 2026

Major Issues Report

Form 8-K - Current report
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 11, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2026

Major Issues Report

Form 8-K - Current report
Apr 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 31, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities